Implication of regulatory networks of long noncoding RNA/circular RNA-miRNA-mRNA in diabetic cardiovascular diseases

Wei Xiong1, Mengran Yao1, Yuqiao Yang1

  • 1Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan province 650032, PR China.

Epigenomics
|November 27, 2020
PubMed

Insights

Diabetic cardiovascular diseases (DCVDs) are a major health threat. This review explores how long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs) form networks that regulate DCVDs, offering potential for new diagnostics and treatments.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiology

Background:

  • Diabetic cardiovascular diseases (DCVDs) represent a significant global health challenge and economic burden, stemming from diabetes mellitus.
  • Noncoding RNAs, including long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), are increasingly recognized for their roles in regulating complex biological processes.
  • These noncoding RNAs, particularly lncRNAs and circRNAs, can function as competing endogenous RNAs (ceRNAs), modulating miRNA activity and subsequently impacting messenger RNA (mRNA) expression.

Purpose of the Study:

  • This review aims to elucidate the mechanistic, pathological, and functional roles of lncRNA/circRNA-miRNA-mRNA networks in the development and progression of DCVDs.
  • It seeks to consolidate current understanding of these intricate regulatory pathways.
  • The review also highlights the potential of these networks for future therapeutic interventions and prognostic evaluations in DCVDs.

Main Methods:

  • This review synthesizes existing research and literature on the involvement of lncRNA, circRNA, and miRNA in diabetic cardiovascular diseases.
  • It focuses on the ceRNA hypothesis, where lncRNAs and circRNAs act as miRNA decoys or sponges.
  • The analysis covers mechanistic insights, pathological contributions, and functional implications of these molecular interactions.

Main Results:

  • lncRNA and circRNA molecules play critical roles in regulating gene expression within the context of DCVDs by interacting with miRNAs.
  • These interactions form complex regulatory networks (lncRNA/circRNA-miRNA-mRNA axes) that significantly influence the pathophysiology of diabetic cardiovascular complications.
  • Dysregulation within these networks contributes to the development and progression of DCVDs.

Conclusions:

  • The lncRNA/circRNA-miRNA-mRNA regulatory networks are integral to the pathogenesis of diabetic cardiovascular diseases.
  • Understanding these networks provides novel insights into the molecular mechanisms underlying DCVDs.
  • Targeting these pathways holds promise for the development of innovative strategies for early detection, treatment, and prognosis of DCVDs.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
691
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K